Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors-Reference-Cited by-同舟云学术

Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors

Published:2008-10 Issue:10 Volume:47 Page:853-859
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosom. Cancer

Author:

Agaram Narasimhan P.,Wong Grace C.,Guo Tianhua,Maki Robert G.,Singer Samuel,DeMatteo Ronald P.,Besmer Peter,Antonescu Cristina R.

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference29 articles.

1. Pathologic and molecular heterogeneity in imatinib-stable or imatinib-responsive gastrointestinal stromal tumors;Agaram;Clin Cancer Res,2007

2. Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors;Antonescu;Clin Cancer Res,2003

3. Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation;Antonescu;Clin Cancer Res,2005

4. L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition;Antonescu;Int J Cancer,2007

5. Mutations of the human PTEN gene;Bonneau;Hum Mutat,2000

Cited by 308 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological Diagnosis and Analysis of Gastrointestinal Stromal Tumors;Advances in Clinical Medicine;2024

2. Molecular features of gastrointestinal stromal tumors “wild-type” (<i>KIT/PDGFRA</i> WT);Advances in Molecular Oncology;2023-12-15

3. Unraveling the Mechanisms of Sensitivity to Anti-FGF Therapies in Imatinib-Resistant Gastrointestinal Stromal Tumors (GIST) Lacking Secondary KIT Mutations;Cancers;2023-11-09

4. Cost Evaluation Analysis of Genetic Testing and Tailored Adjuvant Imatinib in Patients With Resected High-Risk GI Stromal Tumors: The Brazilian Perspective;JCO Global Oncology;2023-09

5. Immunotherapy of gastrointestinal stromal tumors: current view and future directions;Advances in Molecular Oncology;2023-07-10